Jacques F. Acar | Academic Influence

Jacques F. Acar's AcademicInfluence.com Rankings

Jacques F. Acar

Philosophy

#9732

World Rank

#13334

Historical Rank

Logic

#6792

World Rank

#8341

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jacques F. Acar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jacques Fouad Acar was a French doctor and microbiologist who specialized in antibiotics. Biography Acar left Senegal in 1948 for his studies at the Faculté de médecine de Paris. He graduated in 1954 and completed his military service as a field doctor in sub-Saharan Africa. He was appointed head of the clinic for infectious diseases at the Bichat–Claude Bernard Hospital in Paris in 1962.

(See a Problem?)

Jacques F. Acar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bartonella (Rochalimaea) quintana endocarditis in three homeless men. (1995) (337)
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. (2000) (325)
Trends in bacterial resistance to fluoroquinolones. (1997) (295)
Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. (1995) (248)
Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. (1985) (211)
Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. (1992) (176)
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors (1988) (136)
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis (1995) (132)
SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams (1989) (128)
Consequences of bacterial resistance to antibiotics in medical practice. (1997) (127)
Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. (1977) (125)
Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. (1995) (116)
Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. (1970) (114)
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992–93 Western Europe and USA collaborative surveillance study (1996) (111)
Vancomycin-resistant streptococci or Leuconostoc sp (1985) (106)
Antimicrobial resistance: an overview. (2001) (96)
Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci (1990) (95)
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases (1986) (91)
Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. (1986) (91)
Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. (1997) (86)
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997 (2000) (85)
Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus (1978) (85)
Antimicrobial resistance: harmonisation of national antimicrobial resistance monitoring and surveillance programmes in animals and in animal-derived food. (2001) (84)
Expanding indications for the new macrolides, azalides, and streptogramins. (1997) (80)
Antibiotic synergy and antagonism. (2000) (77)
Antimicrobial resistance at farm level. (2006) (76)
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. (2000) (76)
Antimicrobial resistance: responsible and prudent use of antimicrobial agents in veterinary medicine. (2001) (70)
The new quinolones and their combinations with other agents for therapy of severe infections. (1986) (70)
Antibiotic Resistance: An Ecological Perspective on an Old Problem (2009) (70)
Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants. (1971) (67)
New quinolones in the treatment of joint and bone infections. (1988) (65)
Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin. (2001) (64)
Use of penicillin-binding proteins for the identification of enterococci. (1986) (61)
Chloramphenicol Resistance in Streptococcus pneumoniae: Enzymatic Acetylation and Possible Plasmid Linkage (1978) (60)
Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness (1988) (60)
Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams (1983) (59)
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. (2001) (57)
Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Pathogens Associated with Skin and Soft Tissue Infections During 1997 from an International Surveillance Programme (1999) (57)
International comparison of prevalence of resistance to antibiotics. (1978) (56)
Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam) (1986) (56)
Antimicrobial resistance: standardisation and harmonisation of laboratory methodologies for the detection and quantification of antimicrobial resistance. (2001) (56)
Fate of circulating immune complexes in infective endocarditis. (1979) (55)
Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries. (2004) (55)
Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. (1990) (54)
Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. (1985) (51)
A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. (2004) (50)
Antimicrobial susceptibility ofGemella haemolysans isolated from patients with subacute endocarditis (1982) (48)
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. (1990) (48)
Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid (1991) (47)
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997 (1999) (47)
In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. (1983) (46)
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. (1979) (45)
In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases (1990) (44)
The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. (1986) (44)
Serratia marcescens Infections (1986) (41)
Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci. (1989) (41)
Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. (1990) (40)
Antimicrobial resistance: monitoring the quantities of antimicrobials used in animal husbandry. (2001) (39)
Resistance patterns of important gram-positive pathogens. (1988) (39)
Antimicrobial resistance: a complex issue. (2012) (38)
Consequences of increasing resistance to antimicrobial agents. (1998) (38)
Cholera: assessing the risk to travellers and identifying methods of protection. (2003) (38)
Susceptibility survey of piperacillin alone and in the presence of tazobactam. (1993) (34)
A seventeen-year epidemiological survey of antimicrobial resistance in pneumococci in two hospitals. (1988) (33)
Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. (1983) (33)
Synergism and antagonism in double beta-lactam antibiotic combinations. (1986) (32)
Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers. (1983) (30)
The clinical problems of bacterial resistance to the new quinolones. (1990) (30)
Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. (1973) (30)
Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria. (1990) (30)
Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci (1986) (30)
A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. (1992) (29)
Epidemiology of antibiotic resistance in Haemophilus influenzae. (1995) (29)
Activity of imipenem on aerobic bacteria. (1983) (28)
N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci (1994) (28)
Integrating animal health surveillance and food safety: the issue of antimicrobial resistance. (2013) (28)
Problems and changing patterns of resistance with gram-negative bacteria. (1985) (28)
Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins. (1975) (27)
Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile (1986) (27)
In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. (2010) (26)
Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. (1997) (26)
In-vitro antibacterial activity of cefepime: a multicentre study. (1993) (25)
Rapid emergence of resistance to cefepime during treatment. (1998) (24)
A transferable kanamycin resistance plasmid isolated from Haemophilus influenzae. (1975) (24)
Broad- and narrow-spectrum antibiotics: an unhelpful categorization. (1997) (23)
Male fertility and positive Chlamydial serology. A study of 61 fertile and 82 subfertile men. (1987) (23)
Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific assessment Geneva, December 1 – 5, 2003 (2003) (23)
Antimicrobial resistance in animal and public health: introduction and classification of antimicrobial agents. (2012) (23)
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. (1996) (22)
Reviews of Infectious Diseases (2016) (21)
Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period. (1981) (20)
Development of resistance to β-lactam antibiotics with special reference to third-generation cephalosporins (1984) (20)
Genetic aspects and epidemiologic implications of resistance to trimethoprim. (1982) (20)
Bacteroides fragilis resistant to metronidazole. (1983) (19)
Endocarditis caused by Capnocytophaga ochracea (1988) (19)
Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. (1982) (19)
In-vitro susceptibility ofNocardia asteroides to 21 β-lactam antibiotics, in combination with three β-lactamase inhibitors, and its relationship to the β-lactamase content (1985) (18)
Nutritionally deficient streptococci: electron microscopic study of 14 strains isolated in bacterial endocarditis. (1980) (18)
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria (1989) (17)
Corynebacterium diphtheriae endocarditis in France. (1993) (16)
Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns. (1976) (16)
Antibiotic resistance problems in the critical care unit. (1998) (15)
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalis. (1999) (15)
Resistance patterns of Haemophilus influenzae. (1999) (15)
New bacteriological aspects of infective endocarditis. (1984) (15)
Bartonella (Rochalimaea) quintana endocarditis in an Algerian farmer. (1996) (15)
Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements (1988) (14)
Endocarditis Caused by Multiply Resistant Bacteroides fragilis: Case Report and Review. (1995) (13)
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group. (1999) (12)
Epidemiology of Quinolone Resistance: Europe and North and South America (2012) (12)
Spontaneous peritonitis in cirrhotic hospital in-patients: retrospective analysis of 101 cases. (1992) (12)
Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae. (1993) (12)
In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. (1985) (11)
Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey. (1998) (11)
[Infectious endocarditis due to Listeria monocytogenes and Cephalosporium]. (1971) (11)
Mechanisms of Beta-Lactam Resistance in (11)
Isolation of Eikenella corrodens from human infections: report of six cases. (1980) (11)
Bacterial persistence in vivo: resistance or tolerance to antibiotics. (1978) (11)
Epidemiological study of Staphylococcus aureus resistance to new quinolones in a university hospital. (1991) (11)
Mediastinitis due to multiple resistant Corynebacterium xerosis. (1993) (11)
An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP). (1984) (11)
New Considerations for Macrolides, Azalides, Streptogramins, and Ketolides (1999) (11)
Evolutionary Aspects of Plasmid Mediated Resistance in a Hospital Environment (1977) (10)
Penicillin-binding proteins of nutritionally variant streptococci (1982) (10)
Strategies in aminoglycoside use and impact upon resistance. (1986) (10)
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. (1996) (10)
A Comparison of Side Effects of Levofloxacin to Other Agents Concerning the Ecological and Microbiological Effects on Normal Human Flora (2001) (9)
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program. (1998) (9)
[Drug sensitivity of Haemophilus sp. and transfer of resistance into E. coli (author's transl)]. (1977) (9)
Recovery period and the exposure of bacteria to subminimal inhibitory concentrations of antibiotics. (1979) (9)
Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients. (1989) (9)
[Polyradiculoneuritis with hyperalbuminorachitis and pleiocytosis after insect bites. Positive reaction for Rickettsia Conori]. (1968) (9)
Molecular epidemiology of resistance to trimethoprim in enterobacteria isolated in a Parisian hospital. (1986) (9)
[Fusobacterium necrophorum septicemia]. (1994) (8)
[Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)]. (1978) (8)
[Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose]. (1989) (8)
Amikacin-containing regimens for treatment of nocardiosis in immunocompromized patients (1987) (8)
R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy. (1986) (7)
Surveillance of resistance against antimicrobial agents. (1999) (7)
Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results (2020) (7)
In-vitro activity of SQ 26,776 against multiply-resistant enterobacteria--preliminary results. (1981) (7)
Comparative efficacy of ciprofloxacin versus josamycin in the treatment of acute, recurrent, or exacerbated bronchitis. (1989) (7)
Antibiotic resistance in nosocomial pulmonary pathogens. (2000) (6)
Pharmacokinetics and bioavailability of intramuscular preparations of ticarcillin. (1982) (6)
The Epidemiology of Bacterial Resistance to Quinolones (2012) (6)
Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics. (1989) (6)
In vitro activity of macrolides against traditional susceptible bacteria (2002) (6)
Vancomycin-Resistant Streptococci or sp. (1985) (6)
Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. The French Study Group. (1994) (6)
Inhibition of Folate Metabolism in Chemotherapy: The Origins and Uses of Co-trimoxazole (2011) (5)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin. (1994) (5)
Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study. (1983) (5)
[Antibody coated bacteria in urinary sediment (author's transl)]. (1976) (5)
Role of Deficient Mutants in Microbial Persistence (1971) (5)
Role of β-Lactamases in the Resistance of Gram-Negative Bacilli to β-Lactam Antibiotics (1986) (4)
Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins. (1984) (4)
[Kinetics of cefotaxime in healthy subjects (author's transl)]. (1981) (4)
Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae. (1985) (4)
Evolution of enzymatic mechanisms of resistance among beta-lactam antibiotics. (1990) (4)
Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistantStreptococcus pneumoniae (2005) (4)
[Clinical incidence of heterogenous resistance of Staphylococcus to penicillin and cephalosporin]. (1967) (4)
Comparative activity of oral cephalosporins against β-lactamase producing pathogens (1992) (4)
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]. (1983) (4)
Clinical and laboratory evaluation of cephalexin in urinary-tract infections. (1969) (4)
[Kingella kingae osteomyelitis]. (1989) (4)
[Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg]. (1998) (3)
Enzyme-linked immunosorbent assay using three different antigen preparations for detection of antibodies toChlamydia trachomatis (1985) (3)
ESGAB breakpoint determination: Clarithromycin (1991) (3)
Appendicitis due to both Streptococcus pneumoniae and Haemophilus influenzae. (1992) (3)
[Clinical efficacy of Auricularum compared with its bacteriologic efficacy in vitro]. (1988) (3)
L'antibiotique en milieu osseux (1974) (3)
Mechanisms of beta-lactam resistance inHaemophilus influenzae (1988) (3)
Symposium on Tissue Penetration of Antibiotics: Stockholm, September 15–16, 1977 (1978) (3)
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. (1982) (3)
Resistance: Genetics and Medical Implications (1983) (3)
Appendicitis due to bothStreptococcus pneumoniae andHaemophilus influenzae (1992) (2)
[Pharmacokinetic study of three amoxycillin formulations for intramuscular injection]. (1982) (2)
Recovery period after exposure of Staphylococcus aureus to sub-inhibitory and bactericidal concentrations of rifampicin: clinical implications. (1984) (2)
Single- and multiple-dose pharmacokinetics of lenampicillin (KBT-1585) in healthy human subjects: comparative studies with amoxicillin. (1985) (2)
Antibiotic-resistant bacteria may outweigh their susceptible homologs. (1996) (2)
Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics. (1986) (2)
[Periprosthetic popliteal abscess caused by Listeria monocytogenes]. (1993) (2)
[Corynebacterium diphtheriae endocarditis complicated by arthritis and cerebral abscess]. (1994) (2)
Identification of Specific Antibiotic Resistance Mechanisms from Routine Susceptibility Testing Results (1980) (2)
[Corynebacterium diphtheriae endocarditis complicated by septic arthritis and cerebral abscess]. (1995) (2)
[Circulating immuns complexes and infections endocarditis. 64 cases (author's transl)]. (1978) (2)
[Bacteriological cultures by laparoscopy in salpingitis (author's transl)]. (1980) (2)
[Classification of antibiotics]. (1977) (2)
Screening for extended-spectrum cephalosporin resistance in Streptococcus pneumoniae. (1994) (2)
[The natural resistance of staphylococci to methicillin and oxacillin]. (1965) (2)
[Ampicillin resistance of Haemophilus influenzae type B]. (1977) (1)
[Comparison of 2 preventive antibiotic treatments in total hip arthroplasty]. (1985) (1)
[In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study]. (1983) (1)
[In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study]. (1985) (1)
The incidence of beta-lactamase-producing pathogens. (1989) (1)
Evaluation of the MS-2 automated antimicrobial susceptibility testing system: Report of a European collaborative study (1982) (1)
Comparative post-antibiotic effect of ofloxacin , ciprofloxacin and sparfloxacin at low concentrations against penicillin susceptible and -resistant S pneumoniae (1994) (1)
Testing Staphylococcus aureus for resistance to β-lactams (1991) (1)
[beta-Lactamases of Branhamella catarrhalis and their phenotypic implications]. (1995) (1)
[Prevention of bacterial endocarditis]. (1985) (1)
Norfloxacin: microbiology-pharmacology-clinical evaluation. (1983) (1)
[In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study]. (1983) (1)
[Measurement of antibiotic concentrations in normal and pathologic cardiac valves (penicillin-streptomycin)]. (1964) (1)
[Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment]. (1986) (1)
Synergistic Effect of Amoxicillin and Cefotaxime against Enterococcus faecalis (1995) (1)
[DRUG COMBINATIONS IN INFECTIOUS PATHOLOGY]. (1964) (1)
[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study]. (1991) (1)
[Antibacterial activity of tobramycin]. (1974) (1)
[Trimethoprim resistance plasmids: transferability and incompatibility groups (author's transl)]. (1977) (1)
[In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study]. (1990) (1)
[Piperacillin in in vitro-in vivo combination]. (1986) (1)
Epidemiology of resistance to diaminopyrimidines. (1993) (1)
Native valve endocarditis due to nutritionally variantStreptococcus adjacens associated withEnterococcus faecium (1995) (1)
[Necrotizing enteritis and geophagia]. (1976) (1)
[Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli]. (1983) (1)
[Vaccination against yellow fever]. (1967) (1)
Which antibiotics for prophylaxis? (1982) (1)
[In vitro activity of roxithromycin against hospital bacteria and the concordance curve]. (1988) (1)
Synergic activity between sulbactam and clavulanic acid onAcinetobacter calcoaceticus. (1983) (1)
SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci. (1995) (1)
Enzyme-linked immunosorbent assay using three different antigen preparations for detection of antibodies to Chlamydia trachomatis. (1985) (1)
Breakpoint determination: Sparfloxacin (1994) (1)
[Septicemia in the elderly (author's transl)]. (1977) (0)
[Intra-abdominal infections due to anaerobic bacteria]. (1977) (0)
Comparative in-vitro evaluation of Sch 29482, a new beta-lactam antibiotic, on enteropathogenic bacteria. (1982) (0)
[Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874]. (1984) (0)
[Prevention of mycotic infection during antibiotic treatment]. (1976) (0)
Resistance mechanisms. (2002) (0)
[Meningitis caused by Nocardia without brain abscess detectable by computed tomography]. (1995) (0)
[Bacteriological aspects of pyurias]. (1974) (0)
[Infectious complications of cardiovascular surgery]. (1965) (0)
Outer membrane alteration and resistance to antimicrobial agents. (1989) (0)
[The principal rules of medical treatment of urinary tract infections]. (1974) (0)
Title Page / Table of Contents, Vol. 18, Suppl. 1, 1973 (1973) (0)
[Present status of anaerobic bacterial infections]. (1977) (0)
RESISTANT STRAINS OF MICROORGANISMS (1997) (0)
Vancomycin-Resistant Streptococci or Leuconostoc sp (1985) (0)
[Urinary tract infections due to multiresistant gram negative bacteria]. (1974) (0)
[Dental focal infections and allergic diseases]. (1969) (0)
[Cyto-bacteriological examination of urine]. (1974) (0)
Consequences of increasing resistance to antimicrobial agents. Discussion (1998) (0)
Surveillance of resistant pathogens and rational use of antibiotics: general remarks. (1998) (0)
[Three new serotypes of "Salmonella" isolated from man (author's transl)]. (1974) (0)
[Urinary infection and pregnancy]. (1977) (0)
Minimum Inhibitory Concentration Determinations for Ceftiofur and Spectinomycin against Pasteurella multocida, Mannheimia spp. and Haemophilus somnus from France, The Netherlands, and Germany (2001) (0)
[Risks in urinary infections]. (1974) (0)
[Clinical evaluation of moxalactam]. (1983) (0)
β-Lactamases in Clinical Isolates Spectrum Implications of Sulbactam/Ampicillin (2012) (0)
[Course of urinary infections under treatment]. (1974) (0)
[Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu]. (1986) (0)
Bacteriostatic and Bactericidal Intel-reactions in Antibiotics belonging to the Streptogramin Group. (1964) (0)
Conferring Cross-Resistance to Several Groups of Antibiotics by Decreased Permeability (0)
[Clinical trial of a new synthetic anticoagulant: LD 4610]. (1972) (0)
[Resistance to rifampicin. In vitro and in vivo studies]. (1969) (0)
[Comparative study of six quinolone antibacterials (author's transl)]. (1977) (0)
SHV-5, a NovelSHV-Typer-Lactamase ThatHydrolyzes Broad- Spectrum Cephalosporins andMonobactams (1989) (0)
[Antibiotic therapy of bacterial infections during kidney insufficiency]. (1972) (0)
Breakpoint determination: Cefepime (1994) (0)
[Bone penetration of cefazoline (author's transl)]. (1982) (0)
Effect of oxygen concentration and pH level on the antistaphylococcal activity of sisomicin and gentamicin (1979) (0)
[Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study]. (1984) (0)
[Letter: Meningococcal cerebrospinal meningitis in Africa. Treatment by a single intramuscular injection of chloramphenicol (oil suspension)]. (1975) (0)
[Resistance of enterobacteria to the sulfonamide-trimethoprim combination. Course during the last 10 years]. (1983) (0)
Conclusion et perspectives (1987) (0)
[Urinary infection and radiologic anomalies of the upper tract]. (1974) (0)
[Antibiotic treatment of staphylococcal septicemias (detailed plan of method)]. (1967) (0)
[Antibiotics in bone infections]. (1974) (0)
[High or low urinary infection]. (1974) (0)
Testing Staphylococcus aureus for resistance to beta-lactams. (1991) (0)
["Pseudomonas aeruginosa" beta-lactamases and sensitivity to carbenicillin (author's transl)]. (1975) (0)
L ’ antibiorésistance : une question complexe (2012) (0)
[Chemotherapy of deep mycosis]. (1970) (0)
[Piperacillin: a choice position]. (1986) (0)
[Urinary infection in adults. Some examples]. (1974) (0)
[Some rules of diagnosis and treatment of infectious endocarditis]. (1962) (0)
[Bacteria isolated in urinary infections]. (1974) (0)
Plasmid mediated resistance to trimethoprim in Enterobacteriaceae isolated in Gran Canaria, Canary Islands (Spain) (1994) (0)
[Treatment of purulent meningitis with ampicillin associated with intraspinal administration of an aminoside (130 treated cases)]. (1971) (0)
[Cefotaxime and antibiotic combinations]. (1987) (0)
[BACTERIOSTATIC AND BACTERICIDAL INTERACTIONS IN ANTIBIOTICS OF THE STREPTOGRAMIN GROUP]. (1964) (0)
ESGAB breakpoint determination: Temafloxacin (1991) (0)
[Bacteriological consequences of the prescription of an antibiotic]. (1974) (0)
Contents, Vol. 9, 1964 (1964) (0)
[Antistaphylococcal drugs]. (1962) (0)
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose]. (1989) (0)
Disease Association of Thailand In Co-operation with Western Pacific Society of Chemotherapy International Advisory Board (2002) (0)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: cefepime. (1994) (0)
[Renal risk in urinary infections: pyelonephritis]. (1974) (0)
[Antibiotic therapy of gram negative bacterial infections]. (1965) (0)
[STUDY OF THE BACTERICIDAL ACTION ON STAPHYLOCOCCUS AUREUS OF COMBINATIONS OF RIFAMYCIN SV WITH OTHER ANTIBIOTICS BY THE CELLOPHANE TRANSFER TECHNIC]. (1963) (0)
[Vaccination against cholera]. (1967) (0)
[Plasmidic resistance of "Haemophilus sp." to aminoglycoside antibiotics: isolation and study of a new phosphotransferase (author's transl)]. (1977) (0)
[The problem of bacterial persistence in gallbladder infections]. (1966) (0)
[What standpoint to take in regard to bacterial resistance to antibiotics in internal medicine]. (1998) (0)
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study]. (1983) (0)
Roundtable discussion: Cephalosporins in the 1990s and beyond (2000) (0)
[SCARLATINIFORM ERUPTIONS ATTRIBUTED TO STAPHYLOCOCCI]. (1965) (0)
Consequences of increasing resistance to antimicrobial agents. Discussion (1998) (0)
Trends in β-lactam resistance among enterobacteriaceae. Discussion (1998) (0)
[Urinary infection and pregnancy]. (1974) (0)
[Urinary infections with low symptomatology: cystitis]. (1974) (0)
[Relationship between serum antibiotic concentration and inhibiting potency of the serum. Application to ampicillin and amoxicillin]. (1975) (0)
[Isolation of beta-hemolytic streptococci in proctology]. (1978) (0)
Worldwide Trends in Resistance (1995) (0)
Search for Protein Cross-reacting with Oprd Antibodies in Pseudomonas Spp. and Related Species (0)
[3 new Salmonella serotypes: S. Pakistan (8:1,v:1,2), S. India (9,46:1,v:1,5), S. Paris (8,20:z10:1,5)]. (1969) (0)
Genes and spectrum : The theoretical limits. Discussion (1998) (0)
[Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals]. (1979) (0)
[Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose]. (1994) (0)
Clinical implications of the microbiological and pharmacokinetic properties of cefoperazone (2005) (0)

This paper list is powered by the following services:

Other Resources About Jacques F. Acar

en.wikipedia.org

What Schools Are Affiliated With Jacques F. Acar?

Jacques F. Acar is affiliated with the following schools:

Sorbonne University

Image Attributions

Image Source for Jacques F. Acar